Pfizer Eyes Three Oncology Biosimilar Launches In 2019 As Sterile Injectables Problems Persist

 
• By Dean Rudge
PfizerHQ
Will Pfizer see US$1bn of biosimilar sales in 2019? • Source: Shutterstock

More from Biosimilars

More from Products